Edgewood Management
DNA icon

Edgewood Management’s Ginkgo Bioworks DNA Stock Holding History

Edgewood Management’s Portfolio DNA Stock Details DNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$307K Hold
50,000
– – ﹤0.01% 85
2025
Q4 		$416K Buy
+50,000
New +$538K ﹤0.01% 80
2024
Q3 		– Sell
-6,250
Closed -$83.6K – 79
2024
Q2 		$83.6K Hold
6,250
– – ﹤0.01% 80
2024
Q1 		$290K Hold
6,250
– – ﹤0.01% 73
2023
Q4 		$423K Hold
6,250
– – ﹤0.01% 67
2023
Q3 		$453K Hold
6,250
– – ﹤0.01% 66
2023
Q2 		$465K Hold
6,250
– – ﹤0.01% 68
2023
Q1 		$333K Buy
6,250
+1,250
+25% +$79.2K ﹤0.01% 71
2022
Q4 		$338K Buy
5,000
+1,250
+33% +$115K ﹤0.01% 72
2022
Q3 		$468K Buy
3,750
+1,250
+50% +$149K ﹤0.01% 66
2022
Q2 		$238K Buy
+2,500
New +$305K ﹤0.01% 73
2022
Q1 		– Sell
-250
Closed -$83K – 85
2021
Q4 		$83K Hold
250
– – ﹤0.01% 84
2021
Q3 		$116K Buy
+250
New +$122K ﹤0.01% 82

Other funds holding DNA

BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
ACG
Anchorage Capital Group New York $436M AUM 38.51% 1-Year Est. Return
EAM
Erste Asset Management Vienna, Austria $10.8B AUM 38.54% 1-Year Est. Return
Legal & General Group
Legal & General Group London, United Kingdom $432B AUM 29.4% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JMFC
J.M. Forbes & Co Boston, Massachusetts $1.18B AUM 27.3% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return